A Study to Evaluate EDP 938 Regimens in Children With RSV
Clinical trial NCT04816721 · COMPLETED
Trial details
- NCT number
- NCT04816721
- Sponsor
- Enanta Pharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-26
- Primary completion
- 2024-08-19
- Enrollment
- 99
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.